Opus Genetics IRD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$106.93M-116% | -$49.59M+27.3% | -$68.2M-17.0% | -$58.28M+0.6% | -$58.62M-1.9% | ||
| $53K0.0% | $53K+6.0% | $50K+35.1% | $37K+60.9% | $23K+130% | ||
| $3.95M+16.2% | $3.4M-0.6% | $3.42M+1.2% | $3.38M+2.7% | $3.29M-2.1% | ||
| —— | —— | —— | —— | —— | ||
| $1.88M+26,757% | $7K-99.1% | $742K+1,961% | $36K+109% | -$409K-286% | ||
| -$3.34M+4.6% | -$3.5M-1,204% | -$268K-111% | $2.43M-44.5% | $4.38M-25.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$5K-25.0% | -$4K+69.2% | ||
| -$38.99M-10.6% | -$35.25M-7.3% | -$32.86M-3.2% | -$31.83M-10.3% | -$28.85M-12.8% | ||
| —— | $0-100% | $302.5K-50.0% | $605K-33.3% | $907.5K-25.0% | ||
| $0— | $0-100% | $1.21M0.0% | $1.21M0.0% | $1.21M0.0% | ||
| $7.65M+31.7% | $5.81M+3.2% | $5.63M+550% | $865K-64.4% | $2.43M-46.0% | ||
| —— | —— | —— | —— | —— | ||
| $57.15M+14.3% | $50.02M+93.0% | $25.91M+19.3% | $21.72M-2.8% | $22.36M+424% | ||
| —— | —— | —— | —— | -$5.37M+73.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | $0-100% | $611.75K-50.0% | $1.22M-33.3% | $1.84M-25.0% | ||
| $53K0.0% | $53K+6.0% | $50K+35.1% | $37K+60.9% | $23K+130% | ||
| -$65.68M-470% | -$11.52M-101% | -$5.73M-251% | $3.79M+31.9% | $2.88M+3,896% | ||
| -$3.34M+4.6% | -$3.5M-1,204% | -$268K-111% | $2.43M-44.5% | $4.38M-25.0% | ||
| —— | —— | —— | $230K-52.2% | $481K-40.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | $57K+33.3% | $42.75K+50.0% | $28.5K+100% | $14.25K— | ||
| —— | $0-100% | $7M-50.0% | $14M-33.3% | $21M-25.0% | ||
| —— | —— | —— | —— | $1.37M— | ||
| —— | $2.3M+2.3% | $2.25M+35.8% | $1.66M+4.5% | $1.58M+583% | ||
| —— | $23M+33.3% | $17.25M+50.0% | $11.5M+100% | $5.75M— | ||
| —— | —— | —— | —— | $5.98M— | ||
| —— | —— | —— | —— | $15.52M— | ||
| —— | —— | —— | —— | —— | ||
| $198K+53.5% | $129K+89.7% | $68K— | $0— | —— | ||
| —— | $0-100% | $238.75K-50.0% | $477.5K-33.3% | $716.25K-25.0% | ||
| —— | $1.05M+33.3% | $789K+50.0% | $526K+100% | $263K— | ||
| —— | —— | —— | -$5K-25.0% | -$4K+69.2% | ||
| $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Opus Genetics generate?
- Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
- Where does Opus Genetics's cash flow data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
